Clinical Trial Update: Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients [Phase 3]

View source ↗

Summary

Phase 3 non-inferiority trial comparing everolimus with low-dose tacrolimus versus mycophenolate mofetil with standard-dose tacrolimus in kidney transplant reci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant

Drugs mentioned

• Everolimus (Zortress) (everolimus)
• Mycophenolate mofetil (CellCept) (mycophenolate mofetil)
• Tacrolimus (Prograf) (tacrolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Kidney Transplant | Phase 3 | Status: COMPLETED | Results posted: 2014-06-06